Total Payments
$33,639
2024 Payments
$30,775
Companies
4
Transactions
38
Payment Breakdown by Category
Consulting$17,993 (53.5%)
Other$12,480 (37.1%)
Travel$1,808 (5.4%)
Food & Beverage$943.69 (2.8%)
Research$415.44 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,993 | 5 | 53.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,480 | 2 | 37.1% |
| Travel and Lodging | $1,808 | 14 | 5.4% |
| Food and Beverage | $943.69 | 15 | 2.8% |
| Unspecified | $415.44 | 2 | 1.2% |
Payments by Type
General
$33,224
36 transactions
Research
$415.44
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $29,429 | 32 | $0 (2024) |
| SpringWorks Therapeutics, Inc. | $3,532 | 3 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $415.44 | 2 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $262.50 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,775 | 32 | Alexion Pharmaceuticals, Inc. ($26,827) |
| 2023 | $2,602 | 5 | Alexion Pharmaceuticals, Inc. ($2,602) |
| 2022 | $262.50 | 1 | Vertex Pharmaceuticals Incorporated ($262.50) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | In-kind items and services | $348.96 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | In-kind items and services | $245.37 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,240.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Food and Beverage | In-kind items and services | $133.88 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $45.96 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $38.98 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,240.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | In-kind items and services | $396.95 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | In-kind items and services | $169.12 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $41.98 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Food and Beverage | Cash or cash equivalent | $34.02 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $19.71 | General |
| Category: Oncology | ||||||
| 10/27/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $73.40 | General |
| Category: Oncology | ||||||
| 10/19/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $37.01 | General |
| 08/21/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Oncology | ||||||
| 06/30/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $259.37 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 06/21/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: Oncology | ||||||
| 06/04/2024 | SpringWorks Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 06/04/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | Cash or cash equivalent | $195.09 | General |
| 03/08/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | — | In-kind items and services | $156.07 | Research |
| Study: LIBTAYO CLINICAL PUBLICATION PROGRAM • Category: ONCOLOGY | ||||||
| 01/24/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Consulting Fee | Cash or cash equivalent | $10,140.00 | General |
| Category: Oncology | ||||||
| 01/24/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $27.95 | General |
| Category: Oncology | ||||||
| 01/24/2024 | Alexion Pharmaceuticals, Inc. | KOSELUGO (Drug) | Travel and Lodging | Cash or cash equivalent | $20.99 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| LIBTAYO CLINICAL PUBLICATION PROGRAM | Regeneron Pharmaceuticals, Inc. | $415.44 | 2 |
About Dr. Christopher Moertel, MD
Dr. Christopher Moertel, MD is a Pediatric Hematology-Oncology healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720058043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Moertel, MD has received a total of $33,639 in payments from pharmaceutical and medical device companies, with $30,775 received in 2024. These payments were reported across 38 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($17,993).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Minneapolis, MN
- Active Since 01/26/2006
- Last Updated 12/14/2011
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1720058043
Products in Payments
- KOSELUGO (Drug) $29,429
- LIBTAYO (Biological) $415.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Minneapolis
Dr. Margaret Macmillan, Md, MD
Pediatric Hematology-Oncology — Payments: $113,464
Pediatric Hematology-Oncology $113,464
Troy Lund, Md, MD
Pediatric Hematology-Oncology — Payments: $106,257
Pediatric Hematology-Oncology $106,257
Paul Orchard, Md, MD
Pediatric Hematology-Oncology — Payments: $88,393
Pediatric Hematology-Oncology $88,393
Dr. Stephanie Fritch Lilla, Md, MD
Pediatric Hematology-Oncology — Payments: $47,602
Pediatric Hematology-Oncology $47,602
Stephen Nelson, Md, MD
Pediatric Hematology-Oncology — Payments: $18,622
Pediatric Hematology-Oncology $18,622
Christen Ebens, M.d, M.D
Pediatric Hematology-Oncology — Payments: $6,015
Pediatric Hematology-Oncology $6,015